these, to suggest a standard treatment of malaria based upon them.
In Unfortunately the ideal drug has not yet been found, so one must consider how far the remedies at present known fulfil the ideal requirements, and how far their effects may be combined to achieve the best results. The three chief classes of remedy which are generally agreed to be of most use in the treatment of malaria are the cinchona alkaloids, the arsenical preparations, and plasmoquine, so it is necessary to consider these separately.
The only method which has been found absolutely certain for the diagnosis of malarial infection has been the finding of malarial parasites in the blood and this has been the method on which all the cases recorded here were diagnosed. The routine procedure for testing various drugs has been given in detail by Sinton (1926a) [Nov., 1930. (d) Which salt of the alkaloid should be The alkaloids tested were quinine, quinidine, cinchonine, cinchonidine and cinchona febrifuge. The (1) The production of a clinical cure.
The factors which were used in estimating the effects of the different cinchona alkaloids in the production of a clinical cure, were the following:?(a) the effects of treatment on fever, (6) the effects on removing the parasites from the peripheral blood, and (c) the effects on splenic enlargement. (Sinton, 19266; Sinton and Bird, 1929; (Sinton, 1926a; 1926?>) . The (Sinton, 1925; Megaw, Ghosh and Chatterjee, 1928) and emphasizing the necessity for ensuring that the drug is actually taken and retained by the patient (Fletcher, 1923; Sinton, 1926a (Sinton, 1926a, 19266) . The vaunted superiority of the intramuscular method seems to depend entirely on the fact that the greatest care is used ?to ensure that the prescribed dose of the drug is taken and retained, while the patient escapes the unpleasant taste of the drug.
Even assuming that this method of administration gives as good or better results than the oral, it has been shown by many workers that the strength of quinine ordinarily used in such injections gives rise to a very marked necrosis of the tissues into which it is given (Fletcher, 1923; Acton and Chopra, 1924 (Fletcher, 1923) believe that it causes such great irritation that it is of little practical value. It is certainly unsuitable for routine treatment.
There is no doubt that the oral method of administration is that of choice for routine treatment Sinton (1925) and Megaw, Ghosh and Chatterjee (1928 (Sinton, 1926a Sinton (1923a; 19236 (Sinton, 1923a) (Sinton, 1930) . Conclusions regarding the use of Arsenical preparations.
(1) Stovarsol and troposan have a marked destructive action on all forms of P. vivax and will rapidly produce a clinical cure.
(2) The action of the drugs is better when combined with quinine.
(3) The relapse rate in cases of chronic benign tertian malaria was found to be smaller than with the cinchona alkaloids, when these arsenical preparations were given in combination with quinine.
(4) They seem to have a beneficial effect on the general condition of the patients.
(5) The precautions necessary to prevent toxic manifestation would seem to preclude their use as a routine measure and limit it to special cases.
PLASMOQUINE.
About the year 1925 the German chemists Schiilemann, Schonnofer and Wingler manufactured a new synthetic derivative of quinoline which they state to be a salt of alkyl-amino-6-mcthoxyquinoline with an analogous formula to quinine. The drug was found to have a marked destructive action on certain forms of the malaria parasite and it was believed by some workers that this compound would replace completely the cinchona alkaloids in the treatment of malaria. Unfortunately this has not been found to be the case, but, under certain circumstances, it forms a very useful adjuvant to such treatment and may prove a very important starting point from which to conduct further researches into synthetic drugs for the treatment of malaria.
The drug, originally called Beprochin and now known as Plasmoquine or Plasmochin, has undoubtedly a marked action on the parasites of benign tertian and quartan infections, but, while having a destructive action on the gametocytes of P. falciparum, it has little or no effect on the asexual forms of this parasite.
A great drawback to the drug is the toxic effect which may follow its administration, and from which several instances of death have been reported. The literature on the action of the drug has been fully reviewed by (i) Production of a Clinical Cure.
As in the case of the cinchona alkaloids this has been gauged by the effects of treatment on fever, parasites and splenic erflargement.
(a) Effects on Fever. The consensus of opinion now is that in the case of malignant tertian malaria plasmoquine by itself has little effect on the febrile manifestations of the disease, and that it should always be given in combination with quinine or at least one of the cinchona alkaloids, when this infection is present. Table F summarises the results of the treatment of 183 cases of benign tertian malaria and from this it will be seen that while plasmoquine alone has a distinct action on the average duration of fever in this disease, yet, even when small doses are given, its action is enhanced if quinine is given at the same time. In only one case (PMC) did the fever last more than 3 days; this was probably due to the fact that the patient had severe diarrhoea and vomiting on the 2nd day of treatment, which necessitated a temporary cessation of the drug. (b) Effects on the Persistence of Asexual Parasites in the peripheral blood.
were 15 to 20 grains Sinton, Smith and Pottinger (1930) and these results are tabulated in Table G . and by Sinton, Smith and Pottinger (1930) 
